Literature DB >> 28485840

Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

Gloria S Huang, Alessandro D Santin.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28485840      PMCID： PMC5907932          DOI： 10.1002/cncr.30743

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  20 in total

1.  Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab.

Authors:  Alessandro D Santin; Stefania Bellone; Natalia Buza; Jungmin Choi; Peter E Schwartz; Joseph Schlessinger; Richard P Lifton
Journal:  Clin Cancer Res       Date:  2016-08-02       Impact factor: 12.531

2.  Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.

Authors:  Janice M Mehnert; Anshuman Panda; Hua Zhong; Kim Hirshfield; Sherri Damare; Katherine Lane; Levi Sokol; Mark N Stein; Lorna Rodriguez-Rodriquez; Howard L Kaufman; Siraj Ali; Jeffrey S Ross; Dean C Pavlick; Gyan Bhanot; Eileen P White; Robert S DiPaola; Ann Lovell; Jonathan Cheng; Shridar Ganesan
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

3.  TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.

Authors:  Peyman Tavassoli; Latif A Wafa; Helen Cheng; Amina Zoubeidi; Ladan Fazli; Martin Gleave; Robert Snoek; Paul S Rennie
Journal:  Mol Endocrinol       Date:  2010-02-24

Review 4.  Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge.

Authors:  Ali Naboush; Christopher A J Roman; Iuliana Shapira
Journal:  J Investig Med       Date:  2017-01-19       Impact factor: 2.895

5.  Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?

Authors:  Hyo Sook Bae; Hyesun Kim; Sun Young Kwon; Kyu-Rae Kim; Jae Yun Song; Insun Kim
Journal:  Int J Gynecol Pathol       Date:  2015-01       Impact factor: 2.762

6.  Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.

Authors:  Siming Zhao; Murim Choi; John D Overton; Stefania Bellone; Dana M Roque; Emiliano Cocco; Federica Guzzo; Diana P English; Joyce Varughese; Sara Gasparrini; Ileana Bortolomai; Natalia Buza; Pei Hui; Maysa Abu-Khalaf; Antonella Ravaggi; Eliana Bignotti; Elisabetta Bandiera; Chiara Romani; Paola Todeschini; Renata Tassi; Laura Zanotti; Luisa Carrara; Sergio Pecorelli; Dan-Arin Silasi; Elena Ratner; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Amy L Stiegler; Shrikant Mane; Titus J Boggon; Joseph Schlessinger; Richard P Lifton; Alessandro D Santin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

7.  Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.

Authors:  Hsien-Neng Huang; Ying-Cheng Chiang; Wen-Fang Cheng; Chi-An Chen; Ming-Chieh Lin; Kuan-Ting Kuo
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

Review 8.  Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor.

Authors:  D P McDonnell; S L Dana; P A Hoener; B A Lieberman; M O Imhof; R B Stein
Journal:  Ann N Y Acad Sci       Date:  1995-06-12       Impact factor: 5.691

9.  A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress.

Authors:  Junko Kimura; Su Tien Nguyen; Hanshao Liu; Naoe Taira; Yoshio Miki; Kiyotsugu Yoshida
Journal:  Nucleic Acids Res       Date:  2008-08-06       Impact factor: 16.971

10.  Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.

Authors:  John M Findlay; Francesc Castro-Giner; Seiko Makino; Emily Rayner; Christiana Kartsonaki; William Cross; Michal Kovac; Danny Ulahannan; Claire Palles; Richard S Gillies; Thomas P MacGregor; David Church; Nicholas D Maynard; Francesca Buffa; Jean-Baptiste Cazier; Trevor A Graham; Lai-Mun Wang; Ricky A Sharma; Mark Middleton; Ian Tomlinson
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.